Interact to see
Advertisement
Advertisement
FCAVX vs TACAX
FCAVX vs TACAX Comparison
Open Charts FCAVX vs TACAX
Franklin CA Tax Free Income Adv
Price$6.78
Change+$0.01 (+0.15%)
VolumeN/A
Net Assets13.01B
JHancock CA Municipal Bond A
Price$9.91
Change+$0.01 (+0.10%)
VolumeN/A
Net Assets540.26M
FCAVX vs TACAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
VS
FCAVX vs. TACAX commentary
Nov 27, 2025
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FCAVX is a Hold and TACAX is a Hold.
FUNDAMENTALS
Fundamentals
FCAVX has more cash in the bank: 13B vs. TACAX (540M). FCAVX (3.82) and TACAX (3.66) have matching dividends . FCAVX was incepted earlier than TACAX: FCAVX (24 years) vs TACAX (36 years). TACAX (0.87) is less costly to investors than FCAVX (0.51). TACAX is a more actively managed with annual turnover of: 42.00 vs. FCAVX (7.96). FCAVX has a lower initial minimum investment than TACAX: FCAVX (0) vs TACAX (1000). FCAVX annual gain was more profitable for investors over the last year : 2.00 vs. TACAX (1.03). TACAX return over 5 years is better than : 6.05 vs. FCAVX (-0.33).
| FCAVX | TACAX | FCAVX / TACAX | |
| Total Expense Ratio | 0.51 | 0.72 | 71% |
| Annual Report Gross Expense Ratio | 0.51 | 0.87 | 59% |
| Fund Existence | 24 years | 36 years | - |
| Gain YTD | 2.715 | 1.869 | 145% |
| Front Load | N/A | 4% | - |
| Min. Initial Investment | 0 | 1000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 13B | 540M | 2,407% |
| Annual Yield % from dividends | 3.82 | 3.66 | 104% |
| Returns for 1 year | 2.00 | 1.03 | 193% |
| Returns for 3 years | 12.77 | 13.66 | 93% |
| Returns for 5 years | -0.33 | 6.05 | -5% |
| Returns for 10 years | 7.52 | 25.10 | 30% |
View a ticker or compare two or three
VS
VS
Interact to see
Advertisement
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BIB | 83.58 | 1.47 | +1.79% |
| ProShares Ultra Nasdaq Biotechnology | |||
| SPXX | 17.77 | 0.24 | +1.37% |
| Nuveen S&P 500 Dynamic Overwrite Fund | |||
| MLPD | 25.22 | 0.13 | +0.52% |
| Global X MLP & Engy Infras Cov Cll ETF | |||
| CLM | 8.27 | 0.04 | +0.49% |
| Cornerstone Strategic Value Fund | |||
| BMED | 30.93 | 0.10 | +0.34% |
| iShares Health Innovation Active ETF | |||